Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Baicalin may help treat severe drug-induced skin reactions.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Newly made nicotinamide compounds could potentially treat cancer.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The new skin model can predict how chemicals might cause skin allergies.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

A new mouse model effectively mimics vitiligo for research and drug testing.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.